------------------------------
OMB APPROVAL
------------------------------
OMB Number 3235-0287
Expires: December 31, 2001
Estimated average burden
hours per response ....... 0.5
------------------------------
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 4
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934,
Section 17(a) of the Public Utility Holding Company Act of 1935 or
Section 30(f) of the Investment Company Act of 1940
[X] Check this box if no longer subject to Section 16. Form 4 or Form 5
obligations may continue. See Instruction 1(b).
(Print or Type Response)
================================================================================
1. Name and Address of Reporting Person(*)
Tricolli Mark J.
--------------------------------------------------------------------------------
(Last) (First) (Middle)
c/o Goldman, Sachs & Co., 85 Broad Street
--------------------------------------------------------------------------------
(Street)
New York NY 10004
--------------------------------------------------------------------------------
(City) (State) (Zip)
================================================================================
2. Issuer Name and Ticker or Trading Symbol
ProMedCo Management Company (NASDAQ:PMCO)
================================================================================
3. IRS or Social Security Number of Reporting Person (Voluntary)
================================================================================
4. Statement for Month/Year
June/2000
================================================================================
5. If Amendment, Date of Original (Month/Year)
================================================================================
6. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
[ ] Director [ ] 10% Owner
[ ] Officer (give title below) [ X ] Other (specify below)
Former Director (1)
--------------------------------------------------------------------
================================================================================
7. Individual or Joint/Group Filing
(Check Applicable Line)
[ X ] Form filed by One Reporting Person
[ ] Form filed by More than One Reporting Person
================================================================================
Table I -- Non-Derivative Securities Acquired, Disposed of,
or Beneficially Owned
================================================================================
<TABLE>
<CAPTION>
6.
4. 5. Owner-
Securities Acquired (A) or Amount of ship
3. Disposed of (D) Securities Form: 7.
Transaction (Instr. 3, 4 and 5) Beneficially Direct Nature of
2. Code ------------------------------- Owned at End (D) or Indirect
1. Transaction (Instr. 8) (A) of Month Indirect Beneficial
Title of Security Date ------------ Amount or Price (Instr. 3 (I) Ownership
(Instr. 3) (mm/dd/yy) Code V (D) and 4) (Instr.4) (Instr. 4)
------------------------------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C> <C> <C> <C> <C> <C>
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
====================================================================================================================================
</TABLE>
Reminder: Report on a separate line for each class of securities beneficially
owned directly or indirectly
* If the form is filed by more than one reporting person, see Instruction
4(b)(v).
FORM 4 (continued)
Table II -- Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
Potential persons who are to respond to the collection of information
contained in this form are not required to respond unless the form displays
a currently valid OMB Number.
================================================================================
<TABLE>
<CAPTION>
9. 10.
Number Owner-
of ship
2. Deriv- Form of
Conver- 5. 7. ative Deriv- 11.
sion Number of Title and Amount Secur- ative Nature
or Derivative 6. of Underlying 8. ities Secur- of
Exer- 4. Securities Date Securities Price Bene- ity: In-
cise 3. Trans- Acquired (A) Exercisable and (Instr. 3 and 4) of ficially Direct direct
Price Trans- action or Disposed Expiration Date ---------------- Deriv- Owned (D) or Bene-
1. of action Code of(D) (Month/Day/Year) Amount ative at End In- ficial
Title of Deriv- Date (Instr. (Instr. 3, ---------------- or Secur- of direct Owner-
Derivative ative (Month/ 8) 4 and 5) Date Expira- Number ity Month (I) ship
Security Secur- Day/ ------ ------------ Exer- tion of (Instr. (Instr. (Instr. (Instr.
(Instr. 3) ity Year) Code V (A) (D) cisable Date Title Shares 5) 4) 4) 4)
------------------------------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C> <C> <C> <C> <C> <C> <C> <C> <C> <C> <C>
Warrants to $97.00 6/12/00 C 125,000 Immed(2) 6/12/03 Common 3,125,000 (2) -0- I(1) (1)(3)
purchase Series B Stock
Convertible
Preferred Stock
------------------------------------------------------------------------------------------------------------------------------------
Series B (2) 6/12/00 C 125,000 Immed(2) 6/12/07 Common 3,125,000 (2) (1) I(1) (1)(3)
Convertible Stock
Preferred Stock
------------------------------------------------------------------------------------------------------------------------------------
Series A $2.50 Immed. 6/12/07 Common 17,000,000 (1) I(1) (1)(3)
Convertible Stock
Preferred Stock
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
====================================================================================================================================
</TABLE>
Explanation of Responses: (SEE ATTACHED PAGE)
--------------------------------------------- -----------------------
(**)Signature of Reporting Person Date
Mark J. Tricolli by Attorney-in-fact
** Intentional misstatements or omissions of facts constitute Federal Criminal
Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed.
If space is insufficient, see Instruction 6 for procedure.
Potential persons who are to respond to the collection of information
contained in this form are not required to respond unless the form displays
a currently valid OMB Number.
<PAGE>
Item 1: Mark J. Tricolli
c/o Goldman, Sachs & Co.
85 Broad Street
New York, NY 10004
Item 2: ProMedCo Management Company (NASDAQ:PMCO)
Item 4: June 2000
---------------------------------------------------------------------------
(1) The Reporting Person was an associate of Goldman, Sachs & Co.
("Goldman Sachs") until his resignation on June 30, 2000. In
connection with his resignation from Goldman Sachs, on June 30, 2000,
Mr. Tricolli resigned as a director of ProMedCo Management Company
(the "Company"). Goldman Sachs is an indirect wholly-owned subsidiary
of The Goldman Sachs Group, Inc. ("GS Group"). The Reporting Person
disclaims beneficial ownership of the securities reported herein
except to the extent of his pecuniary interest therein, if any.
(2) On June 12, 2000, the warrants were exercised to purchase 125,000
shares of the Company's Series B Convertible Preferred Stock, par
value $0.01 per share (the "Series B Preferred Stock"), at an exercise
price of $97.00 per share. Each share of Series B Preferred Stock is
convertible at any time at the option of the holder into such number
of fully paid and nonassessable shares of the Company's Common Stock,
par value $0.01 per share (the "Common Stock") as is determined by
dividing (x) the Series B Liquidation Preference (defined below) as of
the conversion date, by (y) the Series B Conversion Price (defined
below) as of the conversion date. The initial conversion price for
Series B Preferred Stock is $4.00 per share, which is subject to
adjustment as provided in the Certificate of Designation of the Series
B Preferred Stock (the "Series B Conversion Price"). The "Series B
Liquidation Preference" is $100.00 per share (as adjusted for any
stock dividends, combinations or splits with respect to such share),
plus an amount equal to all accrued but unpaid dividends (whether or
not declared) on such share.
(3) Goldman Sachs and GS Group may be deemed to own beneficially and
indirectly in the aggregate 20,125,000 shares of Common Stock as a
result of the deemed beneficial ownership of 425,000 shares the
Company's Series A Convertible Preferred Stock, par value $0.01 per
share and 125,000 shares of Series B Preferred Stock by certain
investment partnerships of which Goldman Sachs or affiliates of
Goldman Sachs and GS Group are the general partner or managing
partner.
